Leading source of next-generation adjuvants, innovative lipids and systems.
We are an industry leader in human and veterinary vaccine adjuvants. Leveraging over 80 years of expertise, our collaborations start at all stages of the vaccine manufacturing process. Our comprehensive portfolio of components accelerates the production of complete adjuvant systems.
Croda Pharma stands at the forefront of pharmaceutical innovation, specialising in the development of high purity materials for advanced drug formulations. Our expertise spans high purity excipients, protein delivery, bioprocessing ingredients, innovative lipids, and vaccine adjuvant excellence. By leveraging our extensive knowledge and cutting-edge technologies, we enable next-generation drug delivery solutions that cater to both human and animal health markets. Our pharmaceutical portfolio is unmatched in its quality and effectiveness, ensuring that we meet the most stringent industry standards.
We have substantial investment in GMP and multi-site EXCiPACT accreditation, demonstrating every day the confidence in both ingredient quality and supply chain